Patent · US Active

Method for producing soluble recombinant human-basic fibroblast growth factor (rh-bFGF)

US11248032B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignee

Zhuhai Essex Bio-Pharmaceutical Co., Ltd. · CN

Inventors

Haizhou Fang · Tangxia, CN
Bo Yang · Zhejiang, CN
La Ma · Tangxia, CN
Peimin Dai · Tangxia, CN
Xinzhi Wang · Tangxia, CN
Malcolm Ngiam · Hong Kong, CN
Qi Xue · Nanjing, CN
Yongjun YANG · Longbeilingcun, CN

Key dates

Filing date	Jun 23, 2017
Grant date	Feb 15, 2022
Priority date	—
Expiry date	Jun 23, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a method for producing a soluble recombinant human-basic fibroblast growth factor (rh-bFGF), a recombinant human-basic fibroblast growth factor (rh-bFGF) obtained by the method, and a mutated nucleic acid molecule encoding the recombinant human-basic fibroblast growth factor (rh-bFGF).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.